Skip to main content

Global Navigation

  • Other sites:
  • ECDC
  • European Antibiotic Awareness Day
  • ESCAIDE - Scientific conference
  • Eurosurveillance journal
  • EVIP - Vaccination portal
European Centre for Disease Prevention and Control

European Centre for Disease Prevention and Control

An agency of the European Union

Main Navigation

  • Home
  • All topics: A to Z

Secondary Navigation

  • Newsroom
  • Publications & data
  • Tools
  • About us

Search

Filter by:
Page 9 of 70 // 693 Results found

Data

Evidence of the efficacy of the 9vHPV vaccine

Data set - 30 Mar 2020

Efficacy/effectiveness, immunogenicity, safety and tolerability of the 9-valent HPV vaccine.

  • Human papillomavirus infection
  • Immunisation

Data

Evidence of the immunogenicity of the 9vHPV vaccine

Data set - 30 Mar 2020

Efficacy/effectiveness, immunogenicity, safety and tolerability of the 9-valent HPV vaccine

  • Human papillomavirus infection
  • Immunisation

Data

Evidence of the safety of the 9vHPV vaccine

Data set - 30 Mar 2020

Efficacy/effectiveness, immunogenicity, safety and tolerability of the 9-valent HPV vaccine.

  • Human papillomavirus infection
  • Immunisation
  • Vaccine safety

Data

Evidence of the immunogenicity of the HPV vaccine in HIV-infected men and women

Data set - 30 Mar 2020

Efficacy, immunogenicity, safety and tolerability in other populations not previously targeted by immunisation programmes: HIV-infected

  • HIV infection
  • Human papillomavirus infection
  • Immunisation

Data

Evidence of the safety of the HPV vaccine in HIV-infected men and women

Data set - 30 Mar 2020

Efficacy, immunogenicity, safety and tolerability in other populations not previously targeted by immunisation programmes: HIV-infected men and women

  • HIV infection
  • Human papillomavirus infection
  • Immunisation
  • Vaccine safety

Publication

Guidance on HPV vaccination in EU countries: focus on boys, people living with HIV and 9-valent HPV vaccine introduction

Technical guidance - 30 Mar 2020

This document summarises evidence from studies included in the licensing file of HPV vaccines together with postlicensure, peer-reviewed data and analysis where available. This guidance does not address the safety of HPV vaccines observed during the pre- and post-licensing period.

Guidance on HPV vaccination in EU countries: focus on boys, people living with HIV and 9-valent HPV vaccine introduction - EN - [PDF-1.61 MB]
  • EU/EEA
  • HIV infection
  • Human papillomavirus infection
  • Immunisation
  • Scientific advice
  • Vaccine preventable diseases

Data

Evidence of the efficacy of the HPV vaccines in males

Data set - 30 Mar 2020

Efficacy/effectiveness, immunogenicity, safety and tolerability of HPV vaccines in males

  • Human papillomavirus infection
  • Immunisation
  • Vaccine effectiveness

Publication

Systematic scoping review on social media monitoring methods and interventions relating to vaccine hesitancy

Technical report - 9 Mar 2020

Understanding vaccine hesitancy and social media: which social media platforms do users preferably choose as source of information on vaccination and how does that influence their perceptions of vaccination? A systematic scoping review by ECDC and the Vaccine Confidence Project summarises knowledge and research on social media and vaccination.

Systematic scoping review on social media monitoring methods and interventions relating to vaccine hesitancy - EN - [PDF-1.48 MB]
  • Health communication
  • Immunisation
  • Vaccine hesitancy
  • Vaccine preventable diseases

Data

Vaccination coverage for second dose of a measles-containing vaccine, EU/EEA, 2018

Map - 12 Feb 2020
Period: 01 Jan 2018 - 31 Dec 2018

Vaccination coverage for second dose of a measles-containing vaccine, EU/EEA, 2018

  • EU/EEA
  • Immunisation
  • Measles
  • Surveillance

Peer-Reviewed Publication

Human papillomavirus vaccination coverage, policies, and practical implementation across Europe

Feb 2020 - Vaccine - 38(6):1315-1331

Nguyen-Huu, N.-H., Thilly, N., Derrough, T., Sdona, E., Claudot, F., Pulcini, C., Agrinier, N.

  • Europe
  • Human papillomavirus infection
  • Immunisation
  • Vaccination coverage

Pagination

  • First page « First
  • Previous page ‹‹
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Current page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Next page ››
  • Last page Last »
  • About us

    • What we do
    • Who we are
    • Governance
  • Work with us

    • Vacancies
    • Fellowships
    • Traineeships
    • Procurement and grants
  • Contact ECDC

    • Visit us
    • ECDC press room
    • Social media
Log in to ECDC Extranet
Newsletter RSS

Follow us:

Facebook Twitter Youtube Linked In Vimeo Slide share

Footer Navigation

  • Legal notice
  • Copyright
  • Access to TESSy
  • Personal data protection
  • Language policy
  • Cookies
  • Accessibility
  • Sitemap
© European Centre for Disease Prevention and Control (ECDC) 2021
  • Other sites:
    • ECDC
    • European Antibiotic Awareness Day
    • ESCAIDE - Scientific conference
    • Eurosurveillance journal
    • EVIP - Vaccination portal
  • Search:
  • Home
  • All topics: A to Z
  • Newsroom
  • Publications & data
  • Tools
  • About us